Add Company
Join Now

Plexision Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Plexision's estimated annual revenue is currently $1.4M per year.(i)
  • Plexision's estimated revenue per employee is $155,000

Employee Data

  • Plexision has 9 Employees.(i)
  • Plexision grew their employee count by -10% last year.

Plexision's People

NameTitleEmail/Phone
1
Medical DirectorReveal Email/Phone
2
Clinical Laboratory ScientistReveal Email/Phone
3
Medical Laboratory ScientistReveal Email/Phone
4
Medical Laboratory TechnologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Plexision?

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders. Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells. Testing services for transplant recipients and drug developers are provided at Plexision’s CLIA-certified, central laboratory in Pittsburgh. Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The Pleximmune blood test is the first such test offered for children with liver or intestine transplantation.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9-50%N/A
#2
$0.7M90%N/A
#3
N/A913%N/A
#4
$1M9N/AN/A
#5
$0.7M9-40%N/A